Connected transactions in relation to shandong yifang workshop renovation project and zhonglian pharmaceutical production capacity enhancement technical renovation project
Filed with HKEX · Stock code 570 · · 8 pages · English
(Incorporated in Hong Kong with limited liability) (Stock Code: 570) CONNECTED TRANSACTIONS IN RELATION TO SHANDONG YIFANG WORKSHOP RENOVATION PROJECT AND ZHONGLIAN PHARMACEUTICAL PRODUCTION CAPACITY ENHANCEMENT TECHNICAL RENOVATION PROJECT The Board announces that on 15 September 2026, subsidiaries of the Company entered into the following contracts (the “Contracts”): (1) Shandong Yifang and Phar
China Traditional Chinese Medicine Holdings Co. Ltd. on 6ix
Earlier from China Traditional Chinese Medicine
- Exchange notice - resumption of trading
- Exchange notice - trading halt
- Announcement monthly update on the possible privatisation pursuant to rule 3.7 of the takeovers code
- Voluntary announcement - marketing authorisation for huashi baidu granules
- Inside information renewal of the super & short term commercial paper at the national association of financial market institutional investors
Later from China Traditional Chinese Medicine
- Interim Report 2026
- Letter to Registered Shareholders and Reply Form - Notice of Publication of Interim Report 2026
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Follow China Traditional Chinese Medicine into a list and get an email when it puts out news.
Follow China Traditional Chinese Medicine